Sauter la navigation.


Targeting Mitochondria by Antioxidants will be presented in Berlin next November



1st World Congress on

Targeting Mitochondria:

Strategies, Innovations & Clinical Applications


Berlin, Germany, 18th-19th November 2010


Nowadays, mitochondrial dysfunctions are associated with a panel of pathologies such as cancer, diabetes, neurodegenerative diseases, migraine, infertility, kidney diseases, liver diseases, toxicity of HIV drugs, aging…


Mitochondria are ubiquitous organelles in eukaryotic cells whose primary function is to generate energy supplies in the form of ATP through oxidative phosphorylation. As a consequence, mitochondria produce Reactive Oxygen Species (ROS) and are highly vulnerable to oxidative damage. Moreover, mitochondria play a critical role in Ca2+ homeostasis, apoptosis, aging and development; making mitochondria as an attractive target for drug and antioxidant-delivery strategies.


Pr Marvin Edeas, as chairman of the Scientific Committee and ISANH: “It is becoming a necessity and an urge to know why and how to target mitochondria with bioactive molecules, drugs or nutrients in order to treat and prevent pathologies and chronic diseases....I believe that The future of medicine and human health will probably come through Mitochondria"...


During Targeting Mitochondria 2010, a particular attention will be highlighted to many contradictions and controversies and provide answers and perspectives of mitochondrial use as a target. The aim is also to highlight its applications and potential strategies in the prevention and treatment of many chronic diseases and pathologies.

During this conference, different sessions will be held:


  • Mitochondrial dysfunctions in chronic diseases: recent advances and  conclusions
  • Mitochondria in practice: methods and instruments
  • Strategies to target mitochondria
  • Targeting mitochondria: recent clinical and therapeutics studies
  • Mitochondria and Skin-Ageing


Among Speakers:


Pr M. Edeas, Chairman of ISANH, Paris, France

Pr V. P. Skulachev, Moscow State University, Russia

Dr M. Duchen, University College of London, UK

Dr E. Seppet, University of Tartu, Estonia

Dr A. Lombès, University Pierre et Marie Curie, France

Dr C. J. Hauser, Harvard Medical School, USA

Dr W. J. H. Koopman, Radboud University Nijmegen Medical Center, Netherlands

Dr E. G. Mik, Erasmus Medical Center, Netherlands

Pr J. Glass, John Craig Venter Institute, USA

Dr M. Ristow, University of Jena, Germany

Dr V. Weissig, Midwestern University College of Pharmacy Glendale, USA

Dr V. Gogvadze, Karolinska Institute of Stockolm, Sweden

Dr V. E. Kagan, University of Pittsburg, USA

Dr M. Rojo, University of Bordeaux, France

Dr V. M. Victor Gonzalez, University of Valencia, Spain

Dr P. Schroeder, University of Dusseldorf, Germany

Dr G.-M. Muhr, Manager Ageing Skin, R&D Beiersdorf AG, Hamburg, Germany

Dr M. Boschmann, Experimental and Clinical Research Center, Berlin, Germany

Dr S. Klaus, Charite-University, Berlin, Germany


Targeting Mitochondria 2010 will be held under the patronage of the International Society of Antioxidants in Nutrition and Health (ISANH), the French Society of Antioxidants (SFA) and the Japanese Society of Antioxidants (JSA).


For more information about Targeting Mitochondria 2010:



About ISANH:

The aim of ISANH is to advance the practical applications of antioxidants, in all related fields, with particular reference to health and nutrition, and provide recommendations to ISANH's members, health decision makers and institutions about the last antioxidant trends, uses and problems. In addition, ISANH encourages communication and interaction among researchers, physicians, nutritionists, industrials, food technology and strategic marketing managers through a global antioxidants network, please visit


Contact Press:

Agence Takayama - 15 rue de la Paix - 75002 Paris

Tel : +33 1 55 04 77 55 – Fax : +33 1 55 04 77 57